Qol Medcl Drug Patent Portfolio
Qol Medcl owns 1 orange book drug protected by 3 US patents Given below is the list of Qol Medcl's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9255261 | Ultrapure hypoallergenic solutions of sacrosidase | 07 Feb, 2034 | Active |
| US9469847 | Ultrapure hypoallergenic solutions of sacrosidase | 07 Feb, 2034 | Active |
| US9849161 | Ultrapure hypoallergenic solutions of sacrosidase | 07 Feb, 2034 | Active |
Latest Legal Activities on Qol Medcl's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Qol Medcl.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Yr, Small Entity | 07 Mar, 2024 | US9469847 |
| Payment of Maintenance Fee, 8th Yr, Small Entity | 25 Jul, 2023 | US9255261 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 28 Jun, 2021 | US9849161 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 20 Apr, 2020 | US9469847 |
| Post Issue Communication - Certificate of Correction | 24 Feb, 2020 | US9255261 |
| Post Issue Communication - Certificate of Correction | 18 Feb, 2020 | US9469847 |
| Post Issue Communication - Certificate of Correction | 18 Feb, 2020 | US9849161 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 09 Aug, 2019 | US9255261 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 26 Dec, 2017 | US9849161 |
|
Recordation of Patent Grant Mailed
Critical
| 26 Dec, 2017 | US9849161 |
| Sequence Moved to Public Database | 26 Dec, 2017 | US9849161 |
|
Email Notification
Critical
| 07 Dec, 2017 | US9849161 |
|
Issue Notification Mailed
Critical
| 06 Dec, 2017 | US9849161 |
|
Application Is Considered Ready for Issue
Critical
| 20 Nov, 2017 | US9849161 |
| Dispatch to FDC | 20 Nov, 2017 | US9849161 |
Qol Medcl's Family Patents
Qol Medcl Drug List
Given below is the complete list of Qol Medcl's drugs and the patents protecting them.
1. Sucraid
Sucraid is protected by 3 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US9255261 | Ultrapure hypoallergenic solutions of sacrosidase |
07 Feb, 2034
(9 years from now)
| Active |
| US9469847 | Ultrapure hypoallergenic solutions of sacrosidase |
07 Feb, 2034
(9 years from now)
| Active |
| US9849161 | Ultrapure hypoallergenic solutions of sacrosidase |
07 Feb, 2034
(9 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sucraid's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List